Cormorant Asset Management

Latest statistics and disclosures from Cormorant Asset Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Cormorant Asset Management

Companies in the Cormorant Asset Management portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Turning Point Therapeutics I (TPTX) 6.9 $292M -2% 2.4M 121.85
Atea Pharmaceuticals (AVIR) 6.2 $260M NEW 6.4M 40.53
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) 5.6 $235M NEW 750k 313.74
Spdr Ser Tr S&p Biotech Put Option (XBI) 5.0 $211M +200% 1.5M 140.78
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) 4.4 $187M 500k 373.88
Bridgebio Pharma (BBIO) 3.8 $161M 2.3M 71.11
Forma Therapeutics Hldgs SHS (FMTX) 3.7 $156M +31% 4.5M 34.90
Olema Pharmaceuticals (OLMA) 3.5 $148M NEW 3.2M 46.37
Apellis Pharmaceuticals (APLS) 2.5 $107M 1.9M 57.20
Revolution Medicines (RVMD) 2.4 $99M -5% 2.5M 39.59
Ishares Tr Russell 2000 Etf Put Option (IWM) 2.3 $98M 500k 196.06
Stoke Therapeutics (STOK) 2.1 $89M -6% 1.4M 61.93
Y Mabs Therapeutics (YMAB) 2.0 $82M +18% 1.7M 49.51
C4 Therapeutics Com Stk (CCCC) 1.9 $80M NEW 2.5M 32.14
Alx Oncology Hldgs (ALXO) 1.8 $76M -9% 882k 86.20
Beam Therapeutics (BEAM) 1.8 $76M +16% 924k 81.64
Bioatla (BCAB) 1.8 $75M NEW 2.3M 32.90
Rocket Pharmaceuticals (RCKT) 1.8 $75M 1.4M 54.84
Chemocentryx (CCXI) 1.8 $74M -27% 1.2M 61.92
Immunovant (IMVT) 1.7 $72M -4% 1.6M 46.19
Omeros Corporation (OMER) 1.7 $71M -16% 5.0M 14.29
Mirati Therapeutics (MRTX) 1.7 $71M +18% 325k 219.64
Tarsus Pharmaceuticals (TARS) 1.7 $70M NEW 1.7M 40.81
Avidity Biosciences Ord (RNA) 1.5 $63M 2.5M 25.52
Reata Pharmaceuticals Cl A (RETA) 1.5 $62M +11% 500k 123.62
Praxis Precision Medicines I (PRAX) 1.4 $58M NEW 1.1M 53.75
Zymeworks (ZYME) 1.3 $57M +4% 1.2M 47.26
Acceleron Pharma (XLRN) 1.3 $54M -15% 425k 127.94
Igm Biosciences (IGMS) 1.3 $53M +166% 600k 88.29
Viela Bio 1.2 $51M -9% 1.4M 35.97
Myovant Sciences (MYOV) 1.1 $47M -20% 1.7M 27.62
Biohaven Pharmaceutical Holding (BHVN) 0.9 $36M -15% 425k 85.71
Axonics Modulation Technolog (AXNX) 0.8 $35M 693k 49.92
Aligos Therapeutics (ALGS) 0.8 $35M NEW 1.3M 27.21
Twist Bioscience Corp (TWST) 0.8 $32M -55% 225k 141.29
Sorrento Therapeutics Com New (SRNE) 0.7 $31M -30% 4.5M 6.83
Crispr Therapeutics Namen Akt (CRSP) 0.7 $31M -33% 200k 153.11
908 Devices (MASS) 0.7 $30M NEW 545k 54.10
Galecto (GLTO) 0.6 $27M NEW 2.2M 12.30
Zai Lab Adr (ZLAB) 0.6 $26M 189k 135.34
Blueprint Medicines (BPMC) 0.6 $25M -18% 225k 112.15
Cabaletta Bio (CABA) 0.6 $24M -7% 1.9M 12.48
Silverback Therapeutics (SBTX) 0.6 $23M NEW 500k 46.34
Biontech Se Sponsored Ads (BNTX) 0.5 $22M -15% 275k 81.52
Agenus Com New (AGEN) 0.5 $22M -17% 7.0M 3.18
Tokai Pharmaceuticals 0.5 $21M NEW 1.4M 15.09
Kura Oncology (KURA) 0.5 $21M +30% 650k 32.66
Foghorn Therapeutics (FHTX) 0.5 $20M NEW 1.0M 20.27
Akero Therapeutics (AKRO) 0.5 $19M -13% 743k 25.80
Inspire Med Sys (INSP) 0.4 $19M -16% 100k 188.09
Albireo Pharma (ALBO) 0.4 $19M -28% 500k 37.51
Otonomy (OTIC) 0.4 $17M -19% 2.6M 6.47
Ascendis Pharma A/s Sponsored Adr (ASND) 0.4 $17M -20% 100k 166.78
Intellia Therapeutics Put Option (NTLA) 0.4 $16M NEW 300k 54.40
Axsome Therapeutics (AXSM) 0.4 $16M -20% 200k 81.47
Tcr2 Therapeutics Inc cs (TCRR) 0.4 $16M -16% 500k 30.93
Anaptysbio Inc Common (ANAB) 0.3 $14M 650k 21.50
Pliant Therapeutics (PLRX) 0.3 $14M 611k 22.72
Sarepta Therapeutics (SRPT) 0.3 $12M -17% 70k 170.49
Deciphera Pharmaceuticals (DCPH) 0.3 $11M -20% 200k 57.07
Repare Therapeutics Ord (RPTX) 0.2 $10M -13% 300k 34.30
Health Sciences Acq Corp 2 Ord Shs (HSAQ) 0.2 $10M 800k 12.81
Iteos Therapeutics (ITOS) 0.2 $10M -14% 300k 33.82
Insmed Com Par $.01 (INSM) 0.2 $10M -14% 300k 33.29
Akouos (AKUS) 0.2 $9.9M 500k 19.83
Theravance Biopharma (TBPH) 0.2 $9.8M -15% 550k 17.77
Harpoon Therapeutics (HARP) 0.2 $9.5M 571k 16.61
Bctg Acquisition Corp (BCTG) 0.2 $9.2M 800k 11.44
Springworks Therapeutics (SWTX) 0.2 $9.1M NEW 125k 72.52
Uniqure Nv SHS (QURE) 0.2 $9.0M -23% 250k 36.13
Argenx Se Sponsored Adr (ARGX) 0.2 $8.8M -25% 30k 294.10
Protara Therapeutics Com Stk (TARA) 0.2 $8.5M -22% 350k 24.21
4d Molecular Therapeutics In (FDMT) 0.2 $8.3M NEW 200k 41.45
Gossamer Bio (GOSS) 0.2 $8.2M +241% 848k 9.67
Quotient SHS (QTNT) 0.2 $7.8M -25% 1.5M 5.21
Allakos (ALLK) 0.2 $7.0M -33% 50k 140.00
Therapeutics Acquisition Cor Com Cl A (RACA) 0.2 $7.0M 500k 13.95
Morphic Hldg (MORF) 0.2 $6.7M -20% 200k 33.55
Merus N V (MRUS) 0.1 $6.1M -18% 350k 17.53
Genetron Hldgs Ads (GTH) 0.1 $5.6M -20% 400k 14.00
Bcls Acquisition Corp Com Cl A (BLSA) 0.1 $5.5M NEW 500k 11.03
Fs Dev Corp Com Cl A 0.1 $5.5M 500k 11.00
5 01 Acquisition Corp Com Cl A (FVAM) 0.1 $5.1M NEW 500k 10.17
Eiger Biopharmaceuticals (EIGR) 0.1 $4.9M -11% 400k 12.29
Vesper Healthcare Acqstn Cor Unit 99/99/9999 (VSPRU) 0.1 $4.8M 400k 12.12
Replimune Group (REPL) 0.1 $4.8M NEW 125k 38.15
Helix Acquisition Corp Com Cl A (HLXA) 0.1 $4.7M NEW 430k 11.03
Atreca Cl A Com (BCEL) 0.1 $4.7M 294k 16.15
Autolus Therapeutics Spon Ads (AUTL) 0.1 $3.8M 422k 8.94
Kadmon Hldgs (KDMN) 0.1 $3.5M -15% 850k 4.15
Avrobio Ord (AVRO) 0.1 $3.4M 244k 13.94
Panacea Acquisition Corp Unit 99/99/9999 0.1 $3.2M 250k 12.76
Tricida (TCDA) 0.1 $3.0M -41% 428k 7.05
Precision Biosciences Ord (DTIL) 0.1 $2.9M 347k 8.34
Cardiff Oncology (CRDF) 0.1 $2.7M -14% 150k 17.99
Arena Pharmaceuticals Com New (ARNA) 0.0 $1.5M -33% 20k 76.85
Miragen Therapeutics Com New 0.0 $1.5M NEW 93k 16.45
Orchard Therapeutics Ads (ORTX) 0.0 $1.1M 257k 4.32
Fate Therapeutics (FATE) 0.0 $909k -33% 10k 90.90
Cerevel Therapeutics Hldng I *w Exp 06/09/202 (CEREW) 0.0 $753k NEW 133k 5.65
Imv (IMV) 0.0 $716k NEW 234k 3.05
Nektar Therapeutics (NKTR) 0.0 $680k -20% 40k 17.00
X4 Pharmaceuticals (XFOR) 0.0 $669k NEW 104k 6.43
Minerva Neurosciences (NERV) 0.0 $468k -16% 200k 2.34

Past Filings by Cormorant Asset Management

SEC 13F filings are viewable for Cormorant Asset Management going back to 2013

View all past filings